alexa Pistagremic Acid |OMICS International| Chemotherapy: Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

World Clinical Cancer Research and Diagnosis

Tokyo, Japan

2nd European Heart Congress

New York, USA

Global Summit on Petroehemicals

New York, USA

Pistagremic Acid

Researchers have been spending several decades to identify effective agents against cancer which is one of the leading causes of death worldwide. Thus, about 60% of anticancer drugs are structural modification and their analogues from the natural sources such as vinblastine, taxol and camptothecin. However, the management of cancer is still not up to mark and always needs to find out new chemotherapeutic agents. In continuation to our previous investigation on the bioactivities of pistagremic acid , which was evaluated for its cytotoxic effects against NCI 60-cell panel on eight organs (leukemia, non-small cell lung cancer, colon, CNS, melanoma, ovarian, prostate, renal and breast) at National Cancer Institute (NCI) USA, showed significant inhibition to human cancer cell lines.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014

Top